Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Aethlon Medical's price to sales ratio was 73.4× on Jul 31, 2023, against 123.4× a year earlier. Over the last 5 years it ranged from 58.4× to 494.6×, with a median of 228.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 73.4× | −167.2 |
| 2022 | Oct 31, 2022 | 240.6× | +85.5 |
| 2021 | Dec 31, 2021 | 155.1× | −85.6 |
| 2020 | Dec 31, 2020 | 240.7× | +182.3 |
| 2019 | Dec 31, 2019 | 58.4× | −436.2 |
| 2018 | Dec 31, 2018 | 494.6× | +382.2 |
| 2017 | Oct 31, 2017 | 112.4× | −324.0 |
| 2015 | Jul 31, 2015 | 436.3× | +166.3 |
| 2014 | Dec 31, 2014 | 270.1× | +157.8 |
| 2013 | Dec 31, 2013 | 112.3× | +85.1 |
| 2012 | Dec 31, 2012 | 27.2× | – |
See a number that looks wrong?